OcupatchTM is a transdermal drug delivery system for topical treatment of ophthalmic diseases. It is applied to the surface of upper or lower eyelid. The drug in the OcupatchTM is able to penetrate into the eyelid directly that results in more sustained effect than eye drops.
SENJU USA CLINICAL TRIALS
Senju USA has conducted Phase 3 clinical trial with the novel steroid patch.
Study Title: Safety and efficacy study of SUN 131 TDS as compared to Placebo TDS in adults with a chalazion
More details here.
SENJU USA DEVELOPMENT
Senju USA is investigating a unique product in the field of dental and planning to develop a dermal patch product in the field of dermatology to enter the niche markets of dental and dermal disease.